This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
The Intersection Between HIV and COVID-19: Findings From the WHO Global Clinical Platform (preprint)
ssrn; 2021.
Preprint
in English
| PREPRINT-SSRN | ID: ppzbmed-10.2139.ssrn.3963795
ABSTRACT
Background:
Evidence on the association between HIV infection and the risk of poor clinical outcomes in people with COVID-19 remains inconclusive. The World Health Organization (WHO) has established a Global Clinical Platform aimed to assess clinical features and risk factors for severe/fatal COVID-19 among individuals hospitalized with suspected or confirmed SARS-CoV-2 infection.Methods:
Between January 2020-June 2021 anonymized individual-level clinical data from 338,566 patients hospitalized in 38 countries were reported to the WHO Clinical Platform using a standardized set of variables including demographics, vital signs, underlying conditions, laboratory values, therapeutics and medical care received, and clinical outcomes. Descriptive and regression analyses whether HIV status was a risk factor for severity at admission and in-hospital mortality among people hospitalized for COVID-19.Findings:
Of 197,479 patients reporting HIV status, 8.6% (16,955) were living with HIV (PLHIV), and 94.6% (16,283) were from Africa. Among those, 37.1% were male, mean age was 45.5 years, 38.3% were admitted with severe or critical illness and 24.7% died in-hospital. Among 10,166 individuals with information about antiretroviral therapy (ART) status, 91.5% were on ART. When compared to those without HIV, PLHIV had 15% increased odds of severe/critical presentation (aOR=1.15, 95%CI 1.10–1.20) and 38% more likely to die in-hospital (aHR=1.38, 95%CI 1.34-1.41). Among PLHIV, being male, age 45-75 years, having chronic cardiac disease or hypertension increased the odds of severe/critical COVID-19; male sex, age>18 years, having diabetes, hypertension, malignancy, TB, or chronic kidney disease increased the risk of in-hospital mortality.Interpretation:
In this sample of hospitalized people contributing data to the WHO Global Clinical Platform for COVID-19, HIV was a significant independent risk factor for both severe/critical COVID-19 at admission and in-hospital mortality. These findings have informed the WHO COVID-19 Clinical Management Guidelines and SAGE recommendations around COVID-19 vaccination prioritization among vulnerable groups.Funding Information None.Declaration of Interests R.H. received funding from the Wellcome Trust, CIHR UKRI/MRC and ICODA. None of the other authors have any conflicts of interest to disclose.Ethics Approval Statement The analysis plan25 was submitted to the WHO Ethical Review Committee which granted a waiver from ethical review clearance as this was passive, anonymized clinical surveillance. Ethical clearance was obtained, where necessary, by relevant institutional or national bodies.
Full text:
Available
Collection:
Preprints
Database:
PREPRINT-SSRN
Main subject:
HIV Infections
/
Diabetes Mellitus
/
Alzheimer Disease
/
COVID-19
/
Heart Diseases
/
Hypertension
/
Kidney Diseases
Language:
English
Year:
2021
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS